The role of atypical pathogens in nursing home pneumonia

Journal of the American Medical Directors Association

Volumn 3, Issue 5, 2002, Pages 345-346

  Drinka, Paul ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; LEVOFLOXACIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; GERIATRIC CARE; GRAM STAINING; HUMAN; LEGIONELLA; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NURSING HOME; PATHOGENICITY; RISK FACTOR; SPUTUM ANALYSIS; THORAX RADIOGRAPHY;

EID: 0036738797     PISSN: 15258610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-8610(05)70556-9     Document Type: Letter

References (14)

1. Nicolle LE, Bentley DW, Garibaldi R, et al, and SHEA Long-Term-Care Committee. Antimicrobial use in long-term care facilities. Infect Control Hosp Epidemiol 2000;21:537-545.
2. Muder RR. Pneumonia in residents of long-term care facilities: Epidemiology, etiology, management and prevention. Am J Med 1998;105:319-330.
3. Medina-Walpole AM, Katz PR. Nursing home-acquired pneumonia. J Am Geriatr Soc 1999;47:1005-1015.
4. Bartlett JG, Dowell SF, Mandell LA, et al. Practice Guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000;31:347-382.
5. Official statement of the American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Resp Crit Care Med 2001;163:1730.
6. Mandell LA, Marrie TJ, Grossman RF, et al, and the Canadian Community-Acquired Pneumonia Working Group. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000;31:383-421.
7. Marston BJ, Plouffe JF, File TM Jr, et al. Incidence of community-acquired pneumonia requiring hospitalization: Results of a population-based active surveillance study in Ohio. Arch Intern Med 1997;157: 1709-1718.
8. Stout JE, Brennen C, Muder RR. Legionnaires' Disease in a newly constructed long-term care facility. J Am Geriatr Soc 2000;48:1589-1592.
9. Troy CJ, Peeling RW, Ellis AG, et al. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. JAMA 1997;277:1214-1218.
10. Orr PH, Peeling RW, Fast M, et al. Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly. Clin Infect Dis 1996;23:1240-1245.
11. Gleason PP, Mechan TP, Fine JM, et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999;159:2562.
12. Ho PL, Tse WS, Tsang KWT, et al. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: A case control study. Clin Infect Dis 2001;32:701-707.
13. Heffelfinger JD, Dowell SF, Jorgensen JH, et al, and the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Management of community-acquired pneumonia in the era of pneumococcal resistance. Arch Intern Med 2000;160:1399-1408.
14. Hirta-Dulas CAI, Stein DJ, Guay DRP, et al. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. J Am Geriatr Soc 1991;39:979-985.